Homozygosity for autosomal dominant facioscapulohumeral muscular dystrophy (FSHD) does not result in a more severe phenotype

Facioscapulohumeral muscular dystrophy (FSHD) is a relatively common autosomal dominant disorder with an estimated incidence of 1:20 000 births.1 It is clinically characterised by progressive weakness of facial, shoulder girdle, and upper arm muscles; less frequently, the lower limbs are also affected. Some intriguing phenotypic observations are still not understood at the molecular level, such as the existence of clinical anticipation in some multigenerational families, which was observed in several population studies.2–5 In addition, a remarkable inter- and intra-familial clinical variability, ranging from severe infantile forms to asymptomatic or non-penetrant gene carrying, may occur in individuals with an FSHD deleted fragment of the same size. It has been reported that a greater proportion of females than males remain asymptomatic, 1,6 and more recently we have observed that these non-penetrant individuals seem to be concentrated in some families.7 The FSHD1 locus has been mapped to chromosome 4q35, and in most patients the probe p13E-11 detects a polymorphic Eco RI fragment smaller than 35 kb. The size of this fragment ranges from 35 to 300 kb in normal individuals and consists of multiple copies of a tandem repeated 3.3 kb Kpn I unit (D4Z4).8 As the 4q35 region is highly homologous to 10q26, the confirmation of molecular diagnosis is performed using Bln I, which cleaves the 10q26 units only into the 3.3 kb fragments, which are undetectable.9 It has been shown that deletions of an integral number of the chromosome 4 units lead to FSHD and that this contraction might affect nearby genes by altering the chromosomal structure, inducing position effect variegation.10 A polymorphic segment distal to D4Z4 with alleles 4qA and 4qB was described by Van Geel et al .11 In a survey in the Dutch population, Lemmers et al 12 found …

[1]  M. Passos-Bueno,et al.  Asymptomatic carriers and gender differences in facioscapulohumeral muscular dystrophy (FSHD) , 2004, Neuromuscular Disorders.

[2]  S. M. van der Maarel,et al.  Possible phenotypic dosage effect in patients compound heterozygous for FSHD-sized 4q35 alleles , 2003, Neurology.

[3]  P. Giral,et al.  Lipoprotein Lipase Activity and Common Gene Variants in Severely Hypertriglyceridemic Patients with and without Diabetes , 2003, Hormone Research in Paediatrics.

[4]  D. Picketts,et al.  Increasing D4Z4 repeat copy number compromises C2C12 myoblast differentiation , 2003, FEBS letters.

[5]  G. V. Ommen,et al.  Facioscapulohumeral muscular dystrophy is uniquely associated with one of the two variants of the 4q subtelomere , 2002, Nature Genetics.

[6]  Michael R. Green,et al.  Inappropriate Gene Activation in FSHD A Repressor Complex Binds a Chromosomal Repeat Deleted in Dystrophic Muscle , 2002, Cell.

[7]  M. Passos-Bueno,et al.  Facioscapulohumeral (FSHD1) and other forms of muscular dystrophy in the same family: is there more in muscular dystrophy than meets the eye? , 2002, Neuromuscular Disorders.

[8]  P. D. de Jong,et al.  Genomic analysis of human chromosome 10q and 4q telomeres suggests a common origin. , 2002, Genomics.

[9]  L. Sandkuijl,et al.  A new dosage test for subtelomeric 4;10 translocations improves conventional diagnosis of facioscapulohumeral muscular dystrophy (FSHD) , 1999, Journal of medical genetics.

[10]  A. Dürr,et al.  Homozygosity in Huntington’s disease , 1999, Journal of medical genetics.

[11]  A. Shanske,et al.  Central nervous system anomalies in Seckel syndrome: report of a new family and review of the literature. , 1998, American journal of medical genetics.

[12]  M. Passos-Bueno,et al.  The facioscapulohumeral muscular dystrophy (FSHD1) gene affects males more severely and more frequently than females. , 1998, American journal of medical genetics.

[13]  J. Zlotogora Dominance and homozygosity. , 1997, American journal of medical genetics.

[14]  R. Griggs,et al.  Evidence for anticipation and association of deletion size with severity in facioscapulohumerd muscular dystrophy , 1996 .

[15]  G. Deidda,et al.  Direct detection of 4q35 rearrangements implicated in facioscapulohumeral muscular dystrophy (FSHD). , 1996, Journal of medical genetics.

[16]  K. Goto,et al.  DNA rearrangements in Japanese facioscapulohumeral muscular dystrophy patients: clinical correlations , 1995, Neuromuscular Disorders.

[17]  P. Harper,et al.  Correlation between fragment size at D4F104S1 and age at onset or at wheelchair use, with a possible generational effect, accounts for much phenotypic variation in 4q35-facioscapulohumeral muscular dystrophy (FSHD) , 1995, Human molecular genetics.

[18]  K. Mathews,et al.  The DNA rearrangement associated with facioscapulohumeral muscular dystrophy involves a heterochromatin-associated repetitive element: Implications for a role of chromatin structure in the pathogenesis of the disease , 1994, Chromosome Research.

[19]  C. Wijmenga,et al.  Chromosome 4q DNA rearrangements associated with facioscapulohumeral muscular dystrophy , 1992, Nature genetics.

[20]  J. Penney,et al.  Homozygotes for Huntington's disease , 1987, Nature.

[21]  A. Cerqueiraa,et al.  Facioscapulohumeral ( FSHD 1 ) and other forms of muscular dystrophy in the same family : is there more in muscular dystrophy than meets the eye ? , 2002 .

[22]  C. Wijmenga,et al.  High proportion of new mutations and possible anticipation in Brazilian facioscapulohumeral muscular dystrophy families. , 1995, American journal of human genetics.